Inspection Record

Stokes Pharmacy — FDA 483 Findings

US FDAInspected 2016-04-06Published 2024-01-17 3 findingsOther quality systemEquipment and facilityComplaint and recall handling

Inspectors Russell J. GlapionThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Written procedures are not followed for the identification, handling and approval of closures.

2Equipment and facility

Equipment used in the manufacture, processing, packing or holding of drug products· is not of appropriate design to facilitate operations for its intended use arid cleaning and maintenance.

3Complaint and recall handling

Written procedures describing the; handling of all written and oral complaints do not include provisions for review to determine whether the complaint represents a serious and unexpected adverse drug experience which is required to be reported to the Food and Drug Administration .

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Stokes Pharmacy company profile — full history US FDA documents, 2024 Go to Findings search